Synapse - Advanced Practice Providers

Results (87)

Feasibility, tolerability, and patient-reported outcomes with pharmacokinetic (PK)-directed dosing of Evomela (propylene glycol free melphalan) for multiple myeloma and AL amyloidosis patients undergoing autologous hematopoietic stem cell transplant (AHCT)

Meeting Abstract

Shah, G. L.; Lin, A.; Schofield, R.; Sarubbi, C.; Preston, E. V.; Devlin, S. M.; Bhatt, V.; Harnicar, S. J.; Hoover, E.; Chung, D. J.; more...
Blood (2017)

Fulltext@MSK | Save

A phase Ib/IIa trial of the combination of romidepsin, lenalidomide and carfilzomib in patients with relapsed/refractory lymphoma shows complete responses in relapsed and refractory B-and T-cell lymphomas

Meeting Abstract

Mehta-Shah, N.; Moskowitz, A. J.; Lunning, M. A.; Lynch, P.; Scheuerman, M.; Minnal, V.; Galasso, N.; Kumar, A.; Gerecitano, J.; Zelenetz, A. D.; more...
Blood (2017)

Fulltext@MSK | Save

Venetoclax combined with either a hypomethylating agent or low-dose cytarabine shows activity in relapsed and refractory myeloid malignancies

Meeting Abstract

Goldberg, A. D.; Horvat, T. Z.; Hsu, M.; Devlin, S. M.; Cuello, B. M.; Daley, R. J.; King, A. C.; Buie, L. W.; Glass, J. L.; Mauro, M. J.; more...
Blood (2017)

Fulltext@MSK | Save

In vitro, in vivo, and parallel phase I evidence support the safety and activity of duvelisib, a PI3K-δ,γ inhibitor, in combination with romidepsin or bortezomib in relapsed/refractory T-cell lymphoma

Meeting Abstract

Moskowitz, A. J.; Koch, R.; Mehta-Shah, N.; Myskowski, P.; Kheterpal, M.; Dogan, A.; Davey, T.; Galasso, N.; Evan, M.; Shah, M.; more...
Blood (2017)

Fulltext@MSK | Save

Delayed onset subacute atypical hemolytic uremic syndrome (aHUS) post allogeneic stem cell transplantation (SCT)

Meeting Abstract

Boulad, F.; Kernan, N. A.; Scaradavou, A.; Allen, J.; Ruggiero, J.; Torok-Castanza, J.; Zakak, N.; O'Reilly, R. J.; Prockop, S. E.
Bone Marrow Transplantation (2017)

Fulltext@MSK | Save

Vaccines are safe and effective after T-cell depleted CD34-selected allogeneic hematopoietic stem cell transplantation (Allo HCT)

Meeting Abstract

Malard, F.; Shah, G. L.; Seier, K.; Cho, C.; Devlin, S. M.; Maloy, M.; Borrill, T.; Palazzo, M.; van den Brink, M.; Perales, M. A.
Bone Marrow Transplantation (2017)

Fulltext@MSK | Save

Regular low dose sildenafil reduces venous leak rates after radical prostatectomy

Meeting Abstract

Tal, R.; Berookhim, B.; Stember, D.; Jenkins, L.; Narus, J.; Wolchasty, N.; Mulhall, J. P.
Journal of Sexual Medicine (2017)

Fulltext@MSK | Save

An advanced practice provider-led initiative for delirium screening and management in an oncologic ICU

Meeting Abstract

Rebal, S.; Shirzadi, C.; Agatep, J.; Matsoukas, K.; Tayban, K.; Yulico, H.; Tan, K. S.; Seier, K.; Alici, Y.; Korc-Grodzicki, B.; more...
Chest (2017)

Fulltext@MSK | Save

Safety and efficacy of intraventricular (131)I-labeled monoclonal antibody 8H9 targeting the surface glycoprotein B7-H3 in patients with CNS/LM disease

Meeting Abstract

Kramer, K.; Kushner, B.; Modak, S.; Pandit-Taskar, N.; Tomlinson, U.; Donzelli, M.; Wolden, S.; Zanzonico, P.; Humm, J.; Haque, S.; more...
Neuro-Oncology (2017)

Fulltext@MSK | Save

The development of neurologic immune related adverse events (irAEs) in patients with metastatic solid tumors treated with immune checkpoint inhibitors: A single institution retrospective analysis

Meeting Abstract

Malani, R.; Haggiagi, A.; Holder, J.; Shames, Y.; Briggs, S.; Santomasso, B.; Callahan, M.
Neuro-Oncology (2017)

Fulltext@MSK | Save